Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats

Hepatology Research

Volumn 38, Issue 4, 2008, Pages 385-392

  Mostafavi pour, Zohreh ^a,b   Zal, Fatemeh ^a,c   Monabati, Ahmad ^a   Vessal, Mahmood ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant enzymes; Cyclosporine A; Hepatotoxicity; Quercetin; Thiobarbituric acid reacting substances; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CATALASE; CYCLOSPORIN A; FREE RADICAL; GLUTATHIONE PEROXIDASE; IMMUNOSUPPRESSIVE AGENT; OLIVE OIL; PROTEIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DAMAGE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER DYSFUNCTION; LIVER HISTOLOGY; LIVER PROTECTION; LIVER STRUCTURE; LIVER TOXICITY; MALE; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT;

EID: 40049092280     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00273.x     Document Type: Article

References (31)

1. Kahan BD. Immunosuppressive therapy. Curr Opin Immunol 1992; 4: 553-60.
2. Borel J, Baumann G, Chapman I et al. In vivo pharmacological effects of cyclosporine and some analoges. Adv Pharmacol 1996; 35: 115-246.
3. Galan AI, Fernandez E, Moran D, Munoz ME, Jimenez R. Cyclosporine A hepatotoxicity: Effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat. Clin Exp Pharmacol Physiol 1995; 22: 260-5.
4. Remuzzi G, Perico N. Cyclosporine A-induced renal dysfunction in experimental animals and humans. Kidney Int Suppl 1995; 52: S70-4.
5. Wolf A, Trendelenburg CF, Diez-Fernadez C, Pietro P, Cordier A. Role of glutathione in cyclosporine A in vitro hepatotoxicity. Transplant Proc 1994; 26: 2912-14.
6. Wolf A, Trendelenburg CF, Diez-Fernadez C et al. Cyclosporin A-induced oxidative stress in rat hepatocytes. J Pharm Exp Ther 1997; 280: 1328-34.
7. Andres D, Sanz N, Zaragoza A, Alvarez AM, Cascales M. Changes in antioxidant defence systems induced by cyclosporine A in cultures of hepatocytes from 2- and 12-month-old rats. Biochem Pharmacol 2000; 59: 1091-100.
8. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 2000; 15: 718-24.
9. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44: 239-67.
10. Bokov A, Chaudhuri A, Richardson A. The role of oxidative damage and stress in aging. Mech Aging Dev 2004; 125: 811-26.
11. Hillebrand G, Castro LA, Abersetzer R et al. Chronic cyclosporine hepatotoxicity after renal transplantation. Transplant Proc 1999; 18: 1020-2.
12. Rezzani R. Cyclosporine A and adverse effects on organs: Histochemical studies. Prog Histochem Cytochem 2004; 39: 85-128.
13. Durak I, Ozbek H, Elgun S. Cyclosporine reduces hepatic antioxidant capacity: Protective roles of antioxidants. Int Immunopharmacol 2004; 4: 469-73.
14. Hagar HH. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 2004; 151: 335-43.
15. Rezzani R, Buffoli B, Rodella L, Stacchiotti A, Bianchi R. Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver. Int Immunopharmacol 2005; 5: 1397-405.
16. Andres D, Cascales M. Novel mechanism of vitamin E protection against cyclosporine A cytotoxicity in cultured rat hepatocytes. Biochem Pharmacol 2002; 64: 267-76.
17. Zal F, Mostafavi-Pour Z, Vessal M. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A - induced nephrotoxicity. Clin Exp Pharmacol Physiol 2007; 34: 720-4.
18. Satyanarayana PS, Singh D, Chopra K. Quercetin, a bioflavonoid, protects against oxidative stress- related renal dysfunction by cyclosporine in rats. Methods Find Exp Clin Pharmacol 2001; 23: 175-81.
19. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957; 28: 56-63.
20. Bowers GN Jr, McComb RB. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin Chem 1966; 12: 70-89.
21. Gornall AG, Bardwill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 177: 751-66.
22. Robertson WS. Optimizing determination of plasma albumin by the bromocresol green dye binding method. Clin Chem 1981; 27: 144-6.
23. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-54.
24. Hagar HH, El-Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol Physiol 2006; 33: 189-96.
25. Aebi HE. Catalase. In: Bergemyer HU, ed. Methods of Enzymatic Analysis, 3rd edn. Weinheim, West Germany: Verlag Chemie, 1983; 273-86.
26. Misra H, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-5.
27. Fecondo JV, Augusteyn RC. Superoxide dismutase, catalase, and glutathione peroxidase in human cataractous lens. Exp Eye Res 1978; 36: 15-23.
28. Tariq M, Morais C, Sobbi S, Al Sulaiman M, Al Khader A. N-acetylcysteine attenuates cyclosporine-induced nephrotoxicity in rats. Nephrol Dial Transplant 1999; 14: 923-9.
29. Anjaneyulu M, Tirkey N, Chopra K. Attenuation of cyclosporine-induced renal dysfunction by catechin: Possible antioxidant mechanism. Renal Failure 2003; 25: 691-707.
30. Hocherl K, Kees F, Kramer BK, Kurtz A. Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression. Kidney Int 2004; 65: 2071-89.
31. Hsiu SL, Hou YH, Wang YH, Tsao CW, Su SF, Chao PL. Quercetin significantly decreased cyclosporine oral bioavailability in pigs and rats. Life Sci 2002; 72: 227-35.